<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p101" style="overflow: hidden; position: relative; background-color: white; width: 1210px; height: 935px;">
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<style type="text/css" >

#t1_101{left:285px;bottom:860px;letter-spacing:-0.32px;word-spacing:0.06px;}
#t2_101{left:285px;bottom:827px;letter-spacing:-0.27px;}
#t3_101{left:36px;bottom:25px;letter-spacing:0.07px;word-spacing:0.01px;}
#t4_101{left:341px;bottom:30px;}
#t5_101{left:348px;bottom:25px;letter-spacing:0.11px;}
#t6_101{left:377px;bottom:30px;}
#t7_101{left:381px;bottom:25px;letter-spacing:0.07px;word-spacing:-0.1px;}
#t8_101{left:540px;bottom:30px;}
#t9_101{left:546px;bottom:25px;letter-spacing:0.07px;}
#ta_101{left:44px;bottom:77px;letter-spacing:0.1px;word-spacing:-0.05px;}
#tb_101{left:44px;bottom:63px;letter-spacing:0.1px;}
#tc_101{left:996px;bottom:873px;letter-spacing:-0.1px;}
#td_101{left:1043px;bottom:853px;letter-spacing:-0.22px;word-spacing:0.13px;}
#te_101{left:1093px;bottom:833px;letter-spacing:-0.09px;}
#tf_101{left:1106px;bottom:47px;letter-spacing:0.34px;}
#tg_101{left:1121px;bottom:28px;letter-spacing:0.19px;word-spacing:-0.15px;}
#th_101{left:36px;bottom:748px;letter-spacing:-0.09px;}
#ti_101{left:36px;bottom:729px;letter-spacing:-0.09px;}
#tj_101{left:36px;bottom:711px;letter-spacing:-0.09px;}
#tk_101{left:36px;bottom:674px;}
#tl_101{left:47px;bottom:674px;letter-spacing:-0.09px;}
#tm_101{left:47px;bottom:656px;letter-spacing:-0.1px;}
#tn_101{left:47px;bottom:638px;letter-spacing:-0.09px;}
#to_101{left:36px;bottom:619px;letter-spacing:-0.09px;}
#tp_101{left:47px;bottom:601px;letter-spacing:-0.09px;}
#tq_101{left:36px;bottom:583px;letter-spacing:-0.09px;}
#tr_101{left:47px;bottom:564px;letter-spacing:-0.09px;}
#ts_101{left:1091px;bottom:95px;letter-spacing:-0.11px;}
#tt_101{left:492px;bottom:778px;letter-spacing:0.4px;word-spacing:-0.23px;}
#tu_101{left:23px;bottom:915px;letter-spacing:-0.14px;}

.s0_101{font-size:28px;font-family:Arial-BoldMT_5te;color:#000;}
.s1_101{font-size:9px;font-family:ArialMT_5tg;color:#000;}
.s2_101{font-size:5px;font-family:ArialMT_5tg;color:#000;}
.s3_101{font-size:12px;font-family:Arial-BoldMT_5te;color:#000;}
.s4_101{font-size:17px;font-family:ArialMT_5tg;color:#0065A4;}
.s5_101{font-size:17px;font-family:Arial-BoldMT_5te;color:#000;}
.s6_101{font-size:17px;font-family:Arial-BoldMT_jz;color:#000;}
.s7_101{font-size:17px;font-family:Arial-BoldMT_5te;color:#0065A4;}
.s8_101{font-size:11px;font-family:Helvetica, Arial, sans-serif;color:#000;}
</style>
<style id="fonts101" type="text/css" >

@font-face {
	font-family: Arial-BoldMT_5te;
	src: url("fonts/Arial-BoldMT_5te.woff") format("woff");
}

@font-face {
	font-family: Arial-BoldMT_jz;
	src: url("fonts/Arial-BoldMT_jz.woff") format("woff");
}

@font-face {
	font-family: ArialMT_5tg;
	src: url("fonts/ArialMT_5tg.woff") format("woff");
}

</style>
<div id="pg101Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg101" style="-webkit-user-select: none;"><object width="1210" height="935" data="101/101.svg" type="image/svg+xml" id="pdf101" style="width:1210px; height:935px; z-index: 0;"></object></div>
<div class="text-container"><span id="t1_101" class="t s0_101">NCCN Guidelines Version 4.2024 </span>
<span id="t2_101" class="t s0_101">Head and Neck Cancers </span>
<span id="t3_101" class="t s1_101">Version 4.2024, 5/1/2024 © 2024 National Comprehensive Cancer Network </span>
<span id="t4_101" class="t s2_101">® </span>
<span id="t5_101" class="t s1_101">(NCCN </span>
<span id="t6_101" class="t s2_101">® </span>
<span id="t7_101" class="t s1_101">), All rights reserved. NCCN Guidelines </span>
<span id="t8_101" class="t s2_101">® </span>
<span id="t9_101" class="t s1_101">and this illustration may not be reproduced in any form without the express written permission of NCCN. </span>
<span id="ta_101" class="t s3_101">Note: All recommendations are category 2A unless otherwise indicated. </span>
<span id="tb_101" class="t s3_101">Clinical Trials: NCCN believes that the best management of any patient with cancer is in a clinical trial. Participation in clinical trials is especially encouraged. </span>
<span id="tc_101" class="t s4_101">NCCN Guidelines Index </span>
<span id="td_101" class="t s4_101">Table of Contents </span>
<span id="te_101" class="t s4_101">Discussion </span>
<span id="tf_101" class="t s5_101">SURG-A </span>
<span id="tg_101" class="t s5_101">5 OF 8 </span>
<span id="th_101" class="t s5_101">Surgical Management of Cranial Nerves VII, X (including the recurrent laryngeal nerve), XI, and XII </span>
<span id="ti_101" class="t s6_101" data-mappings='[[119,"fl"]]'>Operative management of the facial nerve and other major cranial nerves during primary or regional node resection is inﬂuenced by the </span>
<span id="tj_101" class="t s5_101">preoperative clinical function of the nerve. </span>
<span id="tk_101" class="t s5_101">• </span><span id="tl_101" class="t s6_101" data-mappings='[[41,"ff"]]'>When the nerve is functioning, thorough eﬀorts should be made to preserve the structure and function of the nerve (main trunk and/or </span>
<span id="tm_101" class="t s6_101">branches)—even if otherwise adequate tumor margins are not achieved—recognizing that the surgeon should leave no gross residual </span>
<span id="tn_101" class="t s5_101">disease. </span>
<span id="to_101" class="t s5_101">• Adjuvant postoperative radiation or systemic therapy/RT is generally prescribed when a microscopic residual or gross residual tumor is </span>
<span id="tp_101" class="t s5_101">suspected. </span>
<span id="tq_101" class="t s5_101">• Direct nerve invasion by a tumor and/or preoperative paralysis of the nerve may warrant segmental resection (and sometimes nerve grafting) </span>
<span id="tr_101" class="t s5_101">at the discretion of the surgeon if tumor-free margins are ensured throughout the remainder of the procedure. </span>
<span id="ts_101" class="t s7_101">Continued </span>
<span id="tt_101" class="t s5_101">PRINCIPLES OF SURGERY </span>
<span id="tu_101" class="t s8_101">Printed by Fredd Merc on 8/29/2024 4:45:54 AM. For personal use only. Not approved for distribution. Copyright © 2024 National Comprehensive Cancer Network, Inc., All Rights Reserved. </span></div>

</div>
</body>
</html>
